Search

Organ-on-Chip (OOC) technologies are an innovative approach that replicates human organ structures and functions on microfluidic platforms, providing detailed insights into complex physiological

Joaquín Gómez Moya, executive president of Viva in Vitro, explains in this forum the important role of the NLRP3 inflammasome, popularly known as the “fashionable molecule”, crucial in the

Lung cancer was responsible for 69,225 deaths in the ten years of the study.

The European Commission is committed to combating antibiotic resistance through vaccines, selecting Vaxdyn's competitive project. The entry into clinical phase of K-Vax, the vaccine against Klebsiella

Meet Duponte, our new member. We spoke with Yolima Puentes, CEO.

The result will be an ultra-sensitive biosensor based on DNA origami.

Act4Impact consists of 20 strategic lines of action which will be monitored over time to assess progress.

Situated in London, the UK office is ideally positioned to strengthen our engagement with the global clinical research community.

A good way to identify the right data source for a targeted rare disease is to perform a real-world data (RWD) source mapping exercise by searching the existing literature to find all available RWD

ABTL0812 has been given the International Non-proprietary Designation (INN) ibrilatazar on the recommended list of INNs issued by the World Health Organization (WHO).

The Madrid-based laboratory, together with Histocell and Cardiva, has launched Histokine, located in the Basque Country (Spain). It is the first GMP-certified plant approved by a regulator to

Mats brings over 37 years of experience in the pharmaceutical industry, with a career marked by significant contributions in Discovery, Development, Manufacturing, IT R&D, Patents, Clinical Science

Research and development (R&D) expenses of $4.9m for the half-year ending June 30, 2024. As a result of the completion of the PORTICO clinical trial, the company saves $3.7M compared to the half-year

The core idea of Open innovation is that companies leverage the ideas and resources of external actors such as customers, suppliers, universities, start-ups, etc.